Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Overview
Provider Statement
This continuing medical education activity is provided by 
Support Statement
This activity is supported by an educational grant from Immunocore.
Target Audience
The intended audience for this activity is oncologists and other health care professionals involved in the management of patients with uveal melanoma.
Learning Objectives
Upon successful completion of this educational activity, participants should be better able to:
- Explain the latest understanding regarding the molecular basis of uveal melanoma.
- Critically appraise the latest data regarding the safety and efficacy of new/emerging treatment options for patients with advanced uveal melanoma.
- Outline how new or emerging options may fit into existing treatment algorithms for patients with uveal melanoma.
Activity Chair
Alexander N. Shoushtari, MD
Assistant Attending Physician and Clinical Director, Melanoma Service
Memorial Sloan Kettering Cancer Center
Assistant Professor, Department of Medicine
Weill Cornell Medical College
New York, NY
Faculty
Prof. Dr. med. Jessica C. Hassel
Section Head, Associate Professor
Section of DermatoOncology
Department of Dermatology and National Center for Tumor Diseases
University Hospital Heidelberg
Heidelberg, Germany
Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, December 22, 2021, to December 21, 2022.
How to Participate in This Activity and Obtain CME Credit
To participate in this CME activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 4 of the 5 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Activity Chair and faculty report the following relationship(s)
Alexander N. Shoushtari, MD
Consultant: Bristol-Myers Squibb, Immunocore, Novartis
Prof. Dr. med. Jessica C. Hassel
Advisor: Merck Sharp & Dohme
Speaker for Ineligible Company: Almirall, Bristol-Myers Squibb, GlaxoSmithKline, Merck Sharp & Dohme, Novartis, Pfizer, Roche
Independent Research Contractor: Bristol-Myers Squibb
Reviewer reports the following relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non—FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2021 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com